BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12416681)

  • 21. Mutations in conserved domain I of the Sendai virus L polymerase protein uncouple transcription and replication.
    Chandrika R; Horikami SM; Smallwood S; Moyer SA
    Virology; 1995 Nov; 213(2):352-63. PubMed ID: 7491760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Passage of a Sendai virus recombinant in embryonated chicken eggs leads to markedly rapid accumulation of U-to-C transitions in a limited region of the viral genome.
    Yoshida A; Sakaguchi T; Irie T
    PLoS One; 2012; 7(11):e49968. PubMed ID: 23185501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in conserved domain II of the large (L) subunit of the Sendai virus RNA polymerase abolish RNA synthesis.
    Smallwood S; Easson CD; Feller JA; Horikami SM; Moyer SA
    Virology; 1999 Sep; 262(2):375-83. PubMed ID: 10502516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial characterization of hepatitis A viruses from three intermediate passage levels of a series resulting in adaptation to growth in cell culture and attenuation of virulence.
    Tedeschi V; Purcell RH; Emerson SU
    J Med Virol; 1993 Jan; 39(1):16-22. PubMed ID: 8380839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells.
    Itoh M; Isegawa Y; Hotta H; Homma M
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3207-15. PubMed ID: 9400971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence.
    Huang Z; Panda A; Elankumaran S; Govindarajan D; Rockemann DD; Samal SK
    J Virol; 2004 Apr; 78(8):4176-84. PubMed ID: 15047833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial characterisation of five cloned viruses differing in pathogenicity, obtained from a single isolate of pigeon paramyxovirus type 1 (PPMV-1) following passage in fowls' eggs.
    Fuller CM; Collins MS; Easton AJ; Alexander DJ
    Arch Virol; 2007; 152(8):1575-82. PubMed ID: 17514489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene.
    Kato A; Kiyotani K; Hasan MK; Shioda T; Sakai Y; Yoshida T; Nagai Y
    J Virol; 1999 Nov; 73(11):9237-46. PubMed ID: 10516032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope variation in the Newcastle disease virus HN gene under antibody immune selective pressure in cell culture.
    Gong Y; Cui Z
    Sci China Life Sci; 2011 May; 54(5):474-9. PubMed ID: 21455691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in its hemagglutinin during the adaptation of the influenza virus to mice and their role in the acquisition of virulent properties and resistance to serum inhibitors].
    Shilov AA; Sinitsyn BV
    Vopr Virusol; 1994; 39(4):153-7. PubMed ID: 7998391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleotide sequence analyses of the genes encoding the HN, M, NP, P, and L proteins of two host range mutants of Sendai virus.
    Middleton Y; Tashiro M; Thai T; Oh J; Seymour J; Pritzer E; Klenk HD; Rott R; Seto JT
    Virology; 1990 Jun; 176(2):656-7. PubMed ID: 2161155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of HN protein length diversity to Newcastle disease virus virulence, replication and biological activities.
    Jin J; Zhao J; Ren Y; Zhong Q; Zhang G
    Sci Rep; 2016 Nov; 6():36890. PubMed ID: 27833149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein.
    Bousse T; Takimoto T
    J Virol; 2006 Sep; 80(18):9009-16. PubMed ID: 16940513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation.
    Krishnamurthy S; Huang Z; Samal SK
    Virology; 2000 Dec; 278(1):168-82. PubMed ID: 11112492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
    Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
    Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in conserved domains IV and VI of the large (L) subunit of the sendai virus RNA polymerase give a spectrum of defective RNA synthesis phenotypes.
    Feller JA; Smallwood S; Horikami SM; Moyer SA
    Virology; 2000 Apr; 269(2):426-39. PubMed ID: 10753721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ambisense sendai viruses are inherently unstable but are useful to study viral RNA synthesis.
    Le Mercier P; Garcin D; Hausmann S; Kolakofsky D
    J Virol; 2002 Jun; 76(11):5492-502. PubMed ID: 11991977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant Sendai viruses with L1618V mutation in their L polymerase protein establish persistent infection, but not temperature sensitivity.
    Nishio M; Nagata A; Tsurudome M; Ito M; Kawano M; Komada H; Ito Y
    Virology; 2004 Nov; 329(2):289-301. PubMed ID: 15518809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes.
    Yoshida A; Kawabata R; Honda T; Sakai K; Ami Y; Sakaguchi T; Irie T
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
    Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR
    J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.